Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters
- PMID: 14614746
- PMCID: PMC6808159
- DOI: 10.1002/jcla.10102
Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters
Abstract
Lung cancer, a common malignancy in Taiwan, involves multiple factors, including genetics and environmental factors. The survival time is very short once cancer is diagnosed as being in advanced stage and surgically unresectable. Therefore, a good model of prediction of disease outcome is important for a treatment plan. We investigated the survival time in advanced lung cancer by using computer science from the genetic polymorphism of the p21 and p53 genes in conjunction with patients' general data. We studied 75 advanced and surgical unresectable lung cancer patients. The prediction of survival time was made by comparing real data obtained from follow-up periods with data generated by an artificial neural network (ANN). The most important input variable was the clinical staging of lung cancer patients. The second and third most important variables were pathological type and responsiveness to treatment, respectively. There were 25 neurons in the input layer, four neurons in the hidden layer-1, and one neuron in the output layer. The predicted accuracy was 86.2%. The average survival time was 12.44 +/- 7.95 months according to real data and 13.16 +/- 1.77 months based on the ANN results. ANN provides good prediction results when clinical parameters and genetic polymorphisms are considered in the model. It is possible to use computer science to integrate the genetic polymorphisms and clinical parameters in the prediction of disease outcome. Data mining provides a promising approach to the study of genetic markers for advanced lung cancer.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regression.Cancer Sci. 2003 May;94(5):473-7. doi: 10.1111/j.1349-7006.2003.tb01467.x. Cancer Sci. 2003. PMID: 12824896 Free PMC article.
-
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy.BMC Med Genet. 2010 Nov 30;11:167. doi: 10.1186/1471-2350-11-167. BMC Med Genet. 2010. PMID: 21114867 Free PMC article.
-
Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.Clin Cancer Res. 2010 Apr 15;16(8):2383-90. doi: 10.1158/1078-0432.CCR-09-2793. Epub 2010 Mar 23. Clin Cancer Res. 2010. PMID: 20332326
-
Prognostic molecular markers in non-small cell lung cancer.Lung Cancer. 2001 Dec;34 Suppl 2:S53-8. doi: 10.1016/s0169-5002(01)00345-2. Lung Cancer. 2001. PMID: 11720742 Review.
-
[Genetic prediction, molecular testing and complex treatment of lung cancer].MMW Fortschr Med. 2025 Jun;167(10):52-54. doi: 10.1007/s15006-025-4966-8. MMW Fortschr Med. 2025. PMID: 40467813 Review. German. No abstract available.
Cited by
-
Machine learning for detecting gene-gene interactions: a review.Appl Bioinformatics. 2006;5(2):77-88. doi: 10.2165/00822942-200605020-00002. Appl Bioinformatics. 2006. PMID: 16722772 Free PMC article.
-
The future of artificial intelligence in thoracic surgery for non-small cell lung cancer treatment a narrative review.Front Oncol. 2024 Feb 13;14:1347464. doi: 10.3389/fonc.2024.1347464. eCollection 2024. Front Oncol. 2024. PMID: 38414748 Free PMC article. Review.
-
A Holistic Approach to Implementing Artificial Intelligence in Lung Cancer.Indian J Surg Oncol. 2025 Feb;16(1):257-278. doi: 10.1007/s13193-024-02079-6. Epub 2024 Sep 5. Indian J Surg Oncol. 2025. PMID: 40114896 Review.
-
Exploring the efficacy of artificial neural networks in predicting lung cancer recurrence: a retrospective study based on patient records.Transl Lung Cancer Res. 2023 Oct 31;12(10):2083-2097. doi: 10.21037/tlcr-23-350. Epub 2023 Oct 26. Transl Lung Cancer Res. 2023. PMID: 38025814 Free PMC article.
-
An overview of the use of artificial neural networks in lung cancer research.J Thorac Dis. 2017 Apr;9(4):924-931. doi: 10.21037/jtd.2017.03.157. J Thorac Dis. 2017. PMID: 28523139 Free PMC article.
References
-
- Department of Health, the Executive Yuan. Republic of China, general health statistics , 1997. In: Health and vital statistics. Taipei, Taiwan: R.O.C. Press; 1998. p 86–108.
-
- Finne P, Finne R, Stenman UH. Neural network analysis of clinicopathological factors in urological disease: a critical evaluation of available techniques. BJU Int 2001;88:825–831. - PubMed
-
- Wu YC, Doi K, Giger ML, et al. Reduction of false positives in computerized detection of lung nodules in chest radiographs using artificial neural networks, discriminant analysis, and a rule‐based scheme. J Digit Imaging 1994;7:196–207. - PubMed
-
- Biganzoli E, Boracchi P, Mariani L, et al. Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. Stat Med 1998;17:1169–1186. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous